A worth reading Analysis of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) for the period of 9-Day stands at 65.78% while the stochastic %D for the same period stands at 48.37%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Sell” for Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) while 20-100 Day MACD Oscillator indicates “Sell”.

Bollinger band is a volatility indicator of a certain security, currently Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)’s 20-Day Bollinger Band indicates “Hold”.

About Company

Lexicon Genetics Incorporated is a leader in defining the functions of genes for drug discovery using large-scale knockout mouse technology. Lexicon has invented high-throughput gene trapping technology to discover thousands of genes and expand its OmniBank library of tens of thousands of mouse clones. The Company uses an integrated platform of functional genomic technologies to accelerate large-scale analysis of mammalian gene function for drug discovery.

Previous Day Activity Analysis

On the last trading day, Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) opened the session at $9.82 and after going down -0.82% closed at $9.73. The stock lost -0.09 points in the last trade.

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)’s stock fluctuated in the range of $9.50 and $9.83 during the previous active session. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) traded with the volume of 888055 with average volume of 781.77 Million. The stock has HIGH volatility on the last trading session.

Currently the Beta for the company remains at 0.09 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.49 and 39.11 respectively.

Currently the Insider Ownership of the shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is at 0.1% and the shares outstanding are 105.58 Million.

Important Ratio Analysis

Some important ratios to consider here for Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) are discussed below:

Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The Price to Sale P/S and Price to Book P/B shows the value of 12.79 and 13.15 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 5.22 and 0 correspondingly.

The Quick Ratio of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) stands at 1.6 while the Current Ratio depicts the value of 1.7.

Return on Assets ROA of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is at -34% whereas, Return on Equity ROE and Return of Investment ROI of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) stand at -111.7% and -53% respectively.

Stock Performance Analysis

The stock performance of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) on the basis of 5 day trade show the dip of -0.71% whereas, the monthly performance of the stock shows decrease of -13.2%.

The quarterly performance of the stock remained in red zone with the value of -33.4% while six month performance of the shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) remained bearish with the count of -38.18%.

The yearly and YTD performance of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) remained down at -40.78% and -29.65% respectively.